We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EVCM:NASDAQEverCommerce Inc. Analysis

Data as of 2026-09-27 - not real-time

$8.08

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $8.08, EverCommerce Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 20.1%. With RSI at 45.8 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $6.21 and resistance around $9.40.
The shares look fair, trading on 53.9 times earnings above a sector average of 34.7. Analyst price targets sit 36.1% above the current price. Revenue is growing at 2.7% on a 5.7% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 80.4%, a beta of 0.79 and a maximum drawdown of 52.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

DENVER, Sept. 11, 2026 GLOBE NEWSWIRE -- EverCommerce Inc. NASDAQ: EVCM , a company dedicated to simplifying operations...EverCommerce stock closed at USD 7.77 on September 18, 2026 on Nasdaq, up 1.2 percent and near recenTMCnet6dEverCommerce Strengthens Leadership Team with Focus on Reacceleration of Revenue Growth and Long-Term...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 10.69
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 53.9 versus sector average of 34.7
  • Trading below the 200-day average of 10.69

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 53.9 versus sector average of 34.7
  • Analyst targets imply +36.1% versus the current price
  • 30-day volatility of 80.4%

Key Metrics & Analysis

Financial Health

Revenue Growth2.70%
Profit Margin5.69%
P/E Ratio53.9
ROE3.89%
ROA2.69%
Debt/Equity74.60
P/B Ratio2.0
Op. Cash Flow$106.9M
Free Cash Flow$102.7M
Industry P/E34.7

Technical Analysis

TrendBearish
RSI45.8
Support$6.21
Resistance$9.40
MA 20$7.83
MA 50$9.61
MA 200$10.69
MACDBullish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$5.56
Target Price$11.00
Upside/Downside36.14%
GradeFair
TypeBlend

Risk Assessment

Beta0.79
Volatility80.42%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.